VEGFC and portal hypertension: The importance of these studies in modeling human disease is emphasized by the finding that genetic defects in VEGF-C correlates with increased risk of variceal bleed as a result of portal hypertension in HCV patients with end stage liver disease (Aboismail et al., 2022).